Success Metrics

Clinical Success Rate
79.3%

Based on 46 completed trials

Completion Rate
79%(46/58)
Active Trials
25(26%)
Results Posted
22%(10 trials)
Terminated
12(12%)

Phase Distribution

Ph phase_1
6
6%
Ph not_applicable
30
31%
Ph phase_2
10
10%
Ph phase_3
4
4%

Phase Distribution

6

Early Stage

10

Mid Stage

4

Late Stage

Phase Distribution50 total trials
Phase 1Safety & dosage
6(12.0%)
Phase 2Efficacy & side effects
10(20.0%)
Phase 3Large-scale testing
4(8.0%)
N/ANon-phased studies
30(60.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

78.0%

46 of 59 finished

Non-Completion Rate

22.0%

13 ended early

Currently Active

25

trials recruiting

Total Trials

98

all time

Status Distribution
Active(26)
Completed(46)
Terminated(13)
Other(13)

Detailed Status

Completed46
Recruiting17
unknown12
Terminated12
Active, not recruiting8
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
98
Active
25
Success Rate
79.3%
Most Advanced
Phase 3

Trials by Phase

Phase 16 (12.0%)
Phase 210 (20.0%)
Phase 34 (8.0%)
N/A30 (60.0%)

Trials by Status

not_yet_recruiting11%
unknown1212%
recruiting1717%
completed4647%
suspended11%
withdrawn11%
active_not_recruiting88%
terminated1212%

Recent Activity

Clinical Trials (98)

Showing 20 of 98 trialsScroll for more
NCT07434037

The Neurocognitive Bases of Trust in Intellectual Disability

Recruiting
NCT07469566Not Applicable

Characterization of the Natural History of Microduplication Syndrome 7q11.23

Recruiting
NCT02604563

Aging, Geriatric Syndromes and Clonal Hematopoiesis

Recruiting
NCT04939597Phase 3

A Study to See if Memantine Protects the Brain During Radiation Therapy Treatment for a Brain Tumor

Active Not Recruiting
NCT00772200

Neuropsychological and Behavioral Testing in Younger Patients With Cancer

Completed
NCT03194906Phase 2

Memantine for Prevention of Cognitive Late Effects in Pediatric Patients Receiving Cranial Radiation Therapy for Localized Brain Tumors

Completed
NCT03686280Not Applicable

Resume Walking by an Interactive Mobile Robot of Rehabilitation After Vascular Stroke (Cerebral Vascular Stroke) in Combination With Traditional Reeducation

Completed
NCT06191575

7 Tesla MRI Neuroimaging in Testicular Cancer Patients With Hypogonadism and on Androgen Replacement Therapy

Suspended
NCT00609791Phase 2

Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients of Different Ages With Metastatic Breast Cancer

Active Not Recruiting
NCT03184038Not Applicable

Neurocognition in Patients With Multiple Brain Metastases Treated With Radiosurgery

Recruiting
NCT03678441Not Applicable

Electronic Neurocognitive Tools in Screening for Mental Capability in Patients Undergoing Liver Surgery

Active Not Recruiting
NCT02696993Phase 1

Nivolumab and Radiation Therapy With or Without Ipilimumab in Treating Patients With Brain Metastases From Non-small Cell Lung Cancer

Active Not Recruiting
NCT06868979Not Applicable

Optical Imaging in X-linked Disorders.

Recruiting
NCT03991624Not Applicable

Lack of Decision-making in Patients With Alzheimer's Disease : Functions Involved and the Daily Consequences

Terminated
NCT07109830

Utilizing an EEG-Based BCI Game to Evaluate Cognitive Skills in Children With Motor Impairments

Recruiting
NCT01503086Not Applicable

Computer Training Program for Younger Patients With a Brain Tumor Who Underwent Radiation Therapy

Completed
NCT05106374

Risk of Chemotherapy Toxicity in Older Patients With Blood Cancer or Non-small Cell Lung Cancer

Completed
NCT05379348

Davos Alzheimer's Collaborative Study: Sequential Administration of Digital Testing To Screen For Cognitive Impairment Followed By Blood Based Biomarkers To Assist With Timely Detection And Accurate Diagnosis Of Alzheimer's Disease

Completed
NCT00477958Not Applicable

Assessment Tool for Older Patients With Cancer

Active Not Recruiting
NCT01592968Phase 3

Stereotactic Radiosurgery or Whole Brain Radiation Therapy in Treating Patients With Newly Diagnosed Non-melanoma Brain Metastases

Active Not Recruiting

Drug Details

Intervention Type
OTHER
Total Trials
98